{"id":"W2530569835","doi":"10.1182/blood.v108.11.481.481","title":"MabThera (Rituximab) Plus Cyclophosphamide, Vincristine and Prednisone (CVP) Chemotherapy Improves Survival in Previously Untreated Patients with Advanced Follicular Non-Hodgkin’s Lymphoma (NHL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Confidence interval; Prednisone; Vincristine; Internal medicine; International Prognostic Index; Surgery; Gastroenterology; Cyclophosphamide; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006901135,0.0003068051,0.0006018586,0.000265861,0.0001503288,0.0003485125,0.0002526967,0.0003247654,0.001367608],"category_scores_gemma":[0.0007552264,0.0001948196,0.0004593269,0.0002054903,0.0002604448,0.0002604073,0.0002349276,0.0006858756,0.0003111419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003134813,"about_ca_system_score_gemma":0.0002692316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002432015,"about_ca_topic_score_gemma":0.0009361954,"domain_scores_codex":[0.9996377,0.0002001957,0.00002144639,0.00004342225,0.00005015222,0.00004700495],"domain_scores_gemma":[0.9996929,0.00009374394,0.00008173335,0.00002565886,0.00001235965,0.00009361075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2828893,0.01582468,0.07232923,0.001116783,0.002399518,0.0006393825,0.0004201301,0.002260185,0.06399266,0.0001877795,0.004080529,0.5538599],"study_design_scores_gemma":[0.09972467,0.4294924,0.4445357,0.000189912,0.002537755,0.002300633,0.0001355734,0.003126133,0.01059141,0.0003339997,0.006977084,0.00005479042],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970927,0.002106814,0.0001182842,0.00009577703,0.00003793983,0.00005593086,0.00004593916,0.00001707084,0.0004294675],"genre_scores_gemma":[0.998406,0.000741654,0.0002281062,0.0001257879,0.00007330488,0.00005438477,0.0001268782,0.000002435123,0.0002413302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001367608,"threshold_uncertainty_score":0.004575074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002525771565474547,"score_gpt":0.1970230962256899,"score_spread":0.1944973246602154,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}